Skip to main content
Top
Published in: Annals of Surgical Oncology 2/2007

01-02-2007

Diagnostic Accuracy of Serum-Carcinoembryonic Antigen in Recurrent Colorectal Cancer: A Receiver Operating Characteristic Curve Analysis

Authors: Hartwig Körner, MD, PhD, Kjetil Söreide, MD, Pål Johan Stokkeland, MD, Jon Arne Söreide, MD, PhD, FACS

Published in: Annals of Surgical Oncology | Issue 2/2007

Login to get access

Abstract

Background

Serial measurements of carcinoembryonic antigen (CEA) are frequently used in the follow-up after colorectal cancer (CRC), but its usefulness remains debatable. Choosing the appropriate cut-off point is crucial to the diagnostic accuracy (DA) of continuous test variables. Receiver operating characteristic curve (ROC) analysis is the appropriate statistical method for this purpose, but has not been applied in previous studies.

Methods

One hundred ninety-four consecutive patients surgically treated with curative intent for CRC between July 1996 and June 1999 had systematic follow-up for five years. Follow-up included imaging, coloscopy and serial CEA measurements. Complete data including CEA measurements were available from 153 patients. ROC analysis of CEA was done with regard to detection of recurrent disease.

Results

Depending on the chosen cut-off value of CEA, DA varied widely within the normal range (CEA ≤10 U/ml). CEA >4 U/ml provided the highest sensitivity (0.78) and specificity (0.91), compared to a sensitivity and specificity at the upper normal range (CEA = 10 U/ml) of 0.51 and 0.99, respectively. Thirty-three patients (24%) developed recurrence. Among 11 (5%) asymptomatic patients diagnosed by elevated CEA levels, only two patients (1.5%) were amenable to secondary curative surgery. A threefold increase of CEA in an individual patient had the same DA as the best cut-off value (>4 U/ml).

Conclusions

Diagnostic accuracy of CEA in follow-up after curative surgery for CRC is influenced by the chosen cut-off value. A threefold increase of CEA may indicate recurrent disease. The value of serial measurement of CEA was limited.
Literature
2.
go back to reference Biggs CG, Ballantyne GH. Sensitivity versus cost effectiveness in postoperative follow-up for colorectal cancer. Curr Opin Gen Surg 1994; 94–102 Biggs CG, Ballantyne GH. Sensitivity versus cost effectiveness in postoperative follow-up for colorectal cancer. Curr Opin Gen Surg 1994; 94–102
3.
go back to reference Bruinvels DJ, Stiggelbout AM, Kievit J, et al. Follow-up of patients with colorectal cancer. A meta-analysis. Ann Surg 1994; 219:174–82 Bruinvels DJ, Stiggelbout AM, Kievit J, et al. Follow-up of patients with colorectal cancer. A meta-analysis. Ann Surg 1994; 219:174–82
4.
go back to reference Detry R. Follow-up after curative surgery for colorectal cancer. Acta Gastroenterol Belg 2001; 64:268–71PubMed Detry R. Follow-up after curative surgery for colorectal cancer. Acta Gastroenterol Belg 2001; 64:268–71PubMed
5.
go back to reference Körner H, Söreide K, Stokkeland PJ, Söreide JA. Systematic follow-up after curative surgery for colorectal cancer in Norway: A population-based audit of effectiveness, costs, and compliance. J Gastrointest Surg 2005; 9:320–8PubMedCrossRef Körner H, Söreide K, Stokkeland PJ, Söreide JA. Systematic follow-up after curative surgery for colorectal cancer in Norway: A population-based audit of effectiveness, costs, and compliance. J Gastrointest Surg 2005; 9:320–8PubMedCrossRef
6.
go back to reference Audisio RA, Setti-Carraro P, Segala M, et al. Follow-up in colorectal cancer patients: a cost–benefit analysis. Ann Surg Oncol 1996; 3:349–57PubMedCrossRef Audisio RA, Setti-Carraro P, Segala M, et al. Follow-up in colorectal cancer patients: a cost–benefit analysis. Ann Surg Oncol 1996; 3:349–57PubMedCrossRef
7.
go back to reference Fong Y, Cohen AM, Fortner JG, et al. Liver resection for colorectal metastases. J Clin Oncol 1997; 15:938–46PubMed Fong Y, Cohen AM, Fortner JG, et al. Liver resection for colorectal metastases. J Clin Oncol 1997; 15:938–46PubMed
8.
go back to reference Weber SM, Jarnagin WR, DeMatteo RP, et al. Survival after resection of multiple hepatic colorectal metastases. Ann Surg Oncol 2000; 7:643–50PubMedCrossRef Weber SM, Jarnagin WR, DeMatteo RP, et al. Survival after resection of multiple hepatic colorectal metastases. Ann Surg Oncol 2000; 7:643–50PubMedCrossRef
9.
go back to reference Wanebo JH, Stearns M, Schwartz MK. Use of CEA as an indicator of early recurrence and as a guide to a selected second-look procedure in patients with colorectal cancer. Ann Surg 1978; 188:481–93PubMedCrossRef Wanebo JH, Stearns M, Schwartz MK. Use of CEA as an indicator of early recurrence and as a guide to a selected second-look procedure in patients with colorectal cancer. Ann Surg 1978; 188:481–93PubMedCrossRef
10.
go back to reference Wood CB, Ratcliffe JG, Burt RW, et al. The clinical significance of the pattern of elevated serum carcinoembryonic antigen (CEA) levels in recurrent colorectal cancer. Br J Surg 1980; 67:46–8PubMedCrossRef Wood CB, Ratcliffe JG, Burt RW, et al. The clinical significance of the pattern of elevated serum carcinoembryonic antigen (CEA) levels in recurrent colorectal cancer. Br J Surg 1980; 67:46–8PubMedCrossRef
11.
go back to reference Persijn JP, Hart AA. Prognostic significance of CEA in colorectal cancer: a statistical study. J Clin Chem Clin Biochem 1981; 19:1117–23PubMed Persijn JP, Hart AA. Prognostic significance of CEA in colorectal cancer: a statistical study. J Clin Chem Clin Biochem 1981; 19:1117–23PubMed
12.
go back to reference Armitage NC, Davidson A, Tsikos D, Wood CB. A study of the reliability of carcinoembryonic antigen blood levels in following the course of colorectal cancer. Clin Oncol 1984; 10:141–7PubMed Armitage NC, Davidson A, Tsikos D, Wood CB. A study of the reliability of carcinoembryonic antigen blood levels in following the course of colorectal cancer. Clin Oncol 1984; 10:141–7PubMed
13.
go back to reference Northover J. The use of prognostic markers in surgery for colorectal cancer. Eur J Cancer 1995; 31A:1207–9PubMedCrossRef Northover J. The use of prognostic markers in surgery for colorectal cancer. Eur J Cancer 1995; 31A:1207–9PubMedCrossRef
14.
go back to reference Duffy MJ. Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful? Clin Chem 2001; 47:624–30PubMed Duffy MJ. Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful? Clin Chem 2001; 47:624–30PubMed
15.
go back to reference Wichmann MW, Müller C, Lau-Werner U, et al. The role of carcinoembryonic antigen for the detection of recurrent disease following curative resection of large-bowel cancer. Langenbecks Arch Surg 2000; 385:271–5PubMedCrossRef Wichmann MW, Müller C, Lau-Werner U, et al. The role of carcinoembryonic antigen for the detection of recurrent disease following curative resection of large-bowel cancer. Langenbecks Arch Surg 2000; 385:271–5PubMedCrossRef
16.
go back to reference Chau I, Allen MJ, Cunningham D, et al. The value of routine serum carcino-embryonic antigen measurement and computed tomography in the surveillance of patients after adjuvant chemotherapy for colorectal cancer. J Clin Oncol 2004; 22:1420–9PubMedCrossRef Chau I, Allen MJ, Cunningham D, et al. The value of routine serum carcino-embryonic antigen measurement and computed tomography in the surveillance of patients after adjuvant chemotherapy for colorectal cancer. J Clin Oncol 2004; 22:1420–9PubMedCrossRef
17.
go back to reference Kievit J. Follow-up of patients with colorectal cancer: numbers needed to test and treat. Eur J Cancer 2002; 38:986–99PubMedCrossRef Kievit J. Follow-up of patients with colorectal cancer: numbers needed to test and treat. Eur J Cancer 2002; 38:986–99PubMedCrossRef
18.
go back to reference Wichmann MW, Lau-Werner U, Müller C, et al. Carcinoembryonic antigen for the detection of recurrent disease following curative resection of colorectal cancer. Anticancer Res 2000; 20:4953–5PubMed Wichmann MW, Lau-Werner U, Müller C, et al. Carcinoembryonic antigen for the detection of recurrent disease following curative resection of colorectal cancer. Anticancer Res 2000; 20:4953–5PubMed
19.
go back to reference Robertson EA, Zweig MH. Use of receiver operating characteristic curves to evaluate the clinical performance of analytical systems. Clin Chem 1981; 27:1569–74PubMed Robertson EA, Zweig MH. Use of receiver operating characteristic curves to evaluate the clinical performance of analytical systems. Clin Chem 1981; 27:1569–74PubMed
20.
go back to reference Zweig MH. Evaluation of the clinical accuracy of laboratory tests. Arch Pathol Lab Med 1988; 112:383–6PubMed Zweig MH. Evaluation of the clinical accuracy of laboratory tests. Arch Pathol Lab Med 1988; 112:383–6PubMed
21.
go back to reference Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993; 39:561–77PubMed Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993; 39:561–77PubMed
22.
go back to reference Carriquiry LA, Pineyro A. Should carcinoembryonic antigen be used in the management of patients with colorectal cancer? Dis Colon Rectum 1999; 42:921–9PubMedCrossRef Carriquiry LA, Pineyro A. Should carcinoembryonic antigen be used in the management of patients with colorectal cancer? Dis Colon Rectum 1999; 42:921–9PubMedCrossRef
23.
go back to reference Stajic S, Novakovic R, Kostic N, et al. The importance of monitoring colorectal adenomas by tumor markers (ROC analysis). Med Pregl 1993; 46:69–71PubMed Stajic S, Novakovic R, Kostic N, et al. The importance of monitoring colorectal adenomas by tumor markers (ROC analysis). Med Pregl 1993; 46:69–71PubMed
24.
go back to reference Vallejo J, Torres-Avisbal M, Contreras P, et al. CEA, CA 19.9 and CA 195 in patients with colorectal carcinoma. ROC analysis. Rev Esp Med Nucl 1999; 18:281–6PubMed Vallejo J, Torres-Avisbal M, Contreras P, et al. CEA, CA 19.9 and CA 195 in patients with colorectal carcinoma. ROC analysis. Rev Esp Med Nucl 1999; 18:281–6PubMed
25.
go back to reference Pasanen PA, Eskelinen M, Partanen K, et al. Receiver operating characteristic (ROC) curve analysis of the tumour markers CEA, CA 50 and CA 242 in pancreatic cancer; results from a prospective study. Br J Cancer 1993; 67:852–5PubMed Pasanen PA, Eskelinen M, Partanen K, et al. Receiver operating characteristic (ROC) curve analysis of the tumour markers CEA, CA 50 and CA 242 in pancreatic cancer; results from a prospective study. Br J Cancer 1993; 67:852–5PubMed
26.
go back to reference Silver HK, Archibald BL, Ragaz J, Coldman AJ. Relative operating characteristic analysis and group modeling for tumor markers: comparison of CA 15.3, carcinoembryonic antigen, and mucin-like carcinoma-associated antigen in breast carcinoma. Cancer Res 1991; 51:1904–9PubMed Silver HK, Archibald BL, Ragaz J, Coldman AJ. Relative operating characteristic analysis and group modeling for tumor markers: comparison of CA 15.3, carcinoembryonic antigen, and mucin-like carcinoma-associated antigen in breast carcinoma. Cancer Res 1991; 51:1904–9PubMed
27.
go back to reference Norwegian Gastro-Intestinal Cancer Group (NGICG). Kolorektalcancer og Analcancer. En Veiledning for Leger. Oslo: NGICG, 1999 Norwegian Gastro-Intestinal Cancer Group (NGICG). Kolorektalcancer og Analcancer. En Veiledning for Leger. Oslo: NGICG, 1999
28.
go back to reference Altman DG. Diagnostic tests. In: Practical Statistics for Medical Research. London: Chapman and Hall, 1991:411–416 Altman DG. Diagnostic tests. In: Practical Statistics for Medical Research. London: Chapman and Hall, 1991:411–416
29.
30.
go back to reference Moertel CG, Fleming TR, Macdonald JS, et al. An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. JAMA 1993; 270:943–7PubMedCrossRef Moertel CG, Fleming TR, Macdonald JS, et al. An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. JAMA 1993; 270:943–7PubMedCrossRef
31.
go back to reference Simel DL, Samsa GP, Matchar DB. Likelihood ratios with confidence: sample size estimation for diagnostic test studies. J Clin Epidemiol 1991; 44:763–70PubMedCrossRef Simel DL, Samsa GP, Matchar DB. Likelihood ratios with confidence: sample size estimation for diagnostic test studies. J Clin Epidemiol 1991; 44:763–70PubMedCrossRef
32.
go back to reference Fukuda I, Yamakado M, Kiyose H. Influence of smoking on serum carcinoembryonic antigen levels in subjects who underwent multiphasic health testing and services. J Med Syst 1998; 22:89–93PubMedCrossRef Fukuda I, Yamakado M, Kiyose H. Influence of smoking on serum carcinoembryonic antigen levels in subjects who underwent multiphasic health testing and services. J Med Syst 1998; 22:89–93PubMedCrossRef
33.
go back to reference Wanebo HJ. Cancer trends: the role of CEA in managing colorectal cancer. VA Med 1983; 110:103–8PubMed Wanebo HJ. Cancer trends: the role of CEA in managing colorectal cancer. VA Med 1983; 110:103–8PubMed
Metadata
Title
Diagnostic Accuracy of Serum-Carcinoembryonic Antigen in Recurrent Colorectal Cancer: A Receiver Operating Characteristic Curve Analysis
Authors
Hartwig Körner, MD, PhD
Kjetil Söreide, MD
Pål Johan Stokkeland, MD
Jon Arne Söreide, MD, PhD, FACS
Publication date
01-02-2007
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 2/2007
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-006-9060-6

Other articles of this Issue 2/2007

Annals of Surgical Oncology 2/2007 Go to the issue